Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

Clinical trial NCT03161496 · UNKNOWN

Trial details

NCT number: NCT03161496
Sponsor: Cui Yimin
Status: UNKNOWN
Study type: OBSERVATIONAL

Novel Oral Anticoagulants NOACs Rivaroxaban Apixaban Dabigatran Pharmacokinetics Pharmacodynamics Pharmacogenomics Accurate Medication

Start date: 2017-06-06
Primary completion: 2021-10-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.